Bill > SF3716

This bill: - Regulates the sale of products containing cannabinoids extracted from hemp that are intended for human or animal consumption. It requires these products to be labeled with the manufacturer's information, the testing laboratory, and the amount or percentage of cannabinoids present. It also limits the sale of these products to individuals aged 21 and older. - Clarifies that products meeting the regulation requirements are not controlled substances under the law. However, it prohibits the sale of any other substance extracted or derived from hemp that is intended for external or internal use as a drug or to affect the structure or function of the body. - Establishes testing requirements for these products to ensure they do not contain more than 0.3% tetrahydrocannabinol (THC) and do not have excessive amounts of contaminants like mold, pesticides, or heavy metals. - Provides enforcement mechanisms, allowing the state pharmacy board to treat adulterated or misbranded cannabinoid products as illegal drugs. - Makes a conforming change to the state's controlled substances law to exclude cannabinoid products that meet the regulations from being considered controlled substances.

Health and Social Services

https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF3716&ssn=0&y=2021